Suzhou, China

Xueming Qian

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xueming Qian: Innovator in Antibody Development

Introduction

Xueming Qian is a prominent inventor based in Suzhou, China, known for his significant contributions to the field of antibody development. With a total of two patents to his name, he has made strides in medical applications that address critical health issues.

Latest Patents

Xueming Qian's latest patents include a human IL-4R binding antibody and an anti-CD40 antibody. The first patent focuses on a human IL-4R binding antibody, its antigen binding fragment, and its medical use. This innovation provides a chimeric antibody and a humanized antibody that includes a CDR region from a human IL-4R binding antibody. It also details a pharmaceutical composition that utilizes this antibody for treating allergic diseases. The second patent involves an anti-CD40 antibody, which also includes an antigen binding fragment and its medical applications. This patent highlights the potential of the humanized anti-CD40 antibody in developing drugs for treating CD40-mediated diseases or disorders.

Career Highlights

Throughout his career, Xueming Qian has worked with notable companies such as Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Xueming Qian has collaborated with esteemed colleagues, including Jiahua Jiang and Lianshan Zhang, to further enhance his research and innovations in the field of antibody therapies.

Conclusion

Xueming Qian's work in developing innovative antibodies showcases his commitment to advancing medical science. His patents reflect a dedication to addressing significant health challenges through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…